文献速递临床生化临床免疫

5-氟尿嘧啶治疗药物监测的新分析前因素:采血部位对AUC的影响

Therapeutic drug monitoring (TDM) of 5-fluorouracil (5-FU): new preanalytic aspects.
PubMed 文献 · Clin Chem Lab Med · 2019-01-01

本研究评估在植入式输液港同侧静脉采血是否影响5-FU的AUC测定结果。39例接受持续输注5-FU的患者同时从左右肘静脉采血,用纳米颗粒免疫法测定稳态5-FU浓度。结果显示左右臂AUC无差异(p=0.99),但约半数患者未达到推荐AUC窗(37%偏低、16%偏高)。

要点

  • 输液港同侧肘静脉采血不影响5-FU的AUC测定结果。
  • 约半数患者5-FU剂量未达推荐AUC窗20–30 mg×h×L。
  • 5-FU TDM可用于个体化剂量调整。

核心结论

  • 在植入式输液港同侧肘静脉采血对血浆5-FU浓度测定结果无影响。
  • 高比例患者接受5-FU剂量后未达到推荐的AUC 20–30 [mg×h×L]水平。

研究设计与样本

  • 前瞻性采血对照研究,共纳入39例接受持续输注5-FU的患者。
  • 同时从左右肘静脉采集EDTA血样,稳态下用纳米颗粒免疫法(My5-FU;Saladax)测定5-FU浓度并估算AUC。

主要发现

  • 37%患者AUC低于目标窗,16%患者高于目标窗。
  • 右臂AUC中位数23.3(范围5.8–59.4),左臂中位数23.4(范围5.3–61.0)。
  • 左右臂AUC值差异无统计学意义(p=0.99)。

关键数值与推荐

  • 推荐5-FU AUC范围为20–30 [mg×h×L]。

临床怎么用

  • 可在输液港同侧肘静脉采血进行5-FU AUC监测,无需另选对侧。
  • 应通过TDM评估患者是否达到AUC 20–30 [mg×h×L]以优化个体化剂量。

局限性

  • 样本量39例,结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background 5-Fluorouracil (5-FU) is frequently used for the treatment of gastrointestinal tumors. The pharmacological effect of 5-FU is influenced by genetic polymorphisms as well as differently dosed regimens. Currently, 5-FU is generally administered as a continuous infusion via an implanted port system using a body surface area (BSA)-based dose calculation. In order to optimize treatment, the area under the curve (AUC) can be estimated to allow for individual dose adjustment. A 5-FU AUC range between 20 and 30 [mg×h×L] is recommended. The aim of the current study was to assess if blood for AUC analysis could also be drawn at the side where the port system had been placed. Methods We collected EDTA blood samples of patients receiving infusional 5-FU simultaneously from different sampling points (right/left cubital vein). 5-FU concentrations were measured in a steady-state equilibrium based on nanoparticle immunoassay (My5-FU; Saladax). Results A total of 39 patients took part in this study. About half of the patients did not reach the target 5-FU concentration window (37% were under- and 16% of the patients were overdosed). Calculated median AUC was 23.3 for the right arm (range 5.8-59.4) and a median of 23.4 for the left arm (range 5.3-61.0). AUC values showed no difference between right compared to left arms (p=0.99). Conclusions In all, these results confirm that a high percentage of patients are not treated with 5-FU doses reaching suggested AUC levels of 20-30. The location of venepuncture, however, had no impact on the results of plasma 5-FU concentration.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Mindt S, Aida S, Merx K, et al. Therapeutic drug monitoring (TDM) of 5-fluorouracil (5-FU): new preanalytic aspects. Clin Chem Lab Med. 2019. PMID: 30699067. doi:10.1515/cclm-2018-1177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。